ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune system, the company aims to overcome resistance and deliver more effective, lasting treatments for solid tumors.
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| - | ALKemist Bio | “Home | Alkemist Bio” |